home
programs
directory by group
resources by island
links
contact us
National HIV/AIDS Clinicians' Consultation Center
U.S. State and Jurisdiction Information
Country and Region Information
Epivir (3TC, lamivudine)
A Dose-Ranging Study to Evaluate the Safety and Efficacy of Abacavir Alone or in Combination with Zidovudine and Lamivudine in Antiretroviral Treatment-Naive Subjects (PDF)
ABT-378/Ritonavir Plus Stavudine and Lamivudine for the Treatment of Antiretroviral-Naive Adults with HIV-1 Infection: 48-Week Results (PDF)
Concentrations of Nevirapine, Lamivudine and Stavudine in Semen of HIV-1-Infected Men (PDF)
Dose-Ranging, Randomized, Clinical Trial of Atazanavir with Lamivudine and Stavudine in Antiretroviral-Naive Subjects: 48-Week Results (PDF)
Epivir® (3TC, lamivudine)
Back to HIV Medication Information Back to Non-English Information
Comments/questions about this site to: Kevin Patrick Site and banner created by David Flynn, UH Manoa